Sanofi
No enriched coverage for $SAN.PA in the last 7 days.
European shares traded near flat as strong earnings offset uncertainty on U.S. rates and renewed U.S.-Iran strikes. STOXX 600 was near unchanged, with Germany’s DAX down 0.2% and France’s CAC 40 up 0.6%. Shell reported $9.8B adjusted Q2 profit, more than doubling. Societe Generale, BBVA, Amundi, Schneider Electric, and Sanofi rose; Renault and BMW were weaker.
CAC 40 rose 0.73% to 8,424.14 as investors weighed Middle East tensions and higher oil prices. Brent crude was up 4.41% to $95.02. Airbus gained nearly 6% after announcing a €5 billion buyback and 2026 outlook. TotalEnergies, Engie and other large caps also advanced ahead of an ECB decision.
Recent SAN.PA coverage spans market movers and macro economy.
A full-year sales outlook increase is a positive fundamental update, though the article does not quantify the change.
Sanofi’s move is presented as part of the index’s broad strength, with no new Sanofi catalyst.
alphai scores every news story that mentions SAN.PA with an AI model for sentiment and relevance, and aggregates insider trades from Sanofi's SEC EDGAR Form 4 filings. Figures refresh continuously.
European shares traded near flat as strong earnings offset uncertainty on U.S. rates and renewed U.S.-Iran strikes. STOXX 600 was near unchanged, with Germany’s DAX down 0.2% and France’s CAC 40 up 0.6%. Shell reported $9.8B adjusted Q2 profit, more than doubling. Societe Generale, BBVA, Amundi, Schneider Electric, and Sanofi rose; Renault and BMW were weaker.
6 min readCAC 40 rose 0.73% to 8,424.14 as investors weighed Middle East tensions and higher oil prices. Brent crude was up 4.41% to $95.02. Airbus gained nearly 6% after announcing a €5 billion buyback and 2026 outlook. TotalEnergies, Engie and other large caps also advanced ahead of an ECB decision.
4 min read